Monoclonal antibody as therapy for malignant lymphomas

Comptes rendus biologies
B Coiffier

Abstract

Rituximab was the first monoclonal antibody to have been registered for the treatment of B-cell lymphomas. Randomized studies have demonstrated its activity in follicular lymphoma, mantle-cell lymphoma, and diffuse large B-cell lymphoma in untreated or relapsing patients. Because of its high activity and low toxicity ratio, rituximab has transformed the outcome of patients with B-cell lymphoma. A combination of rituximab plus chemotherapy, R-CHOP, has the highest efficacy ever described with any chemotherapy in diffuse large B-cell lymphoma and follicular lymphoma. The role of radio-labelled antibodies is still to be defined.

References

Jan 25, 2002·The New England Journal of Medicine·Bertrand CoiffierChristian Gisselbrecht
Feb 14, 2002·Seminars in Oncology·Antonio J Grillo-LópezMark Benyunes
Apr 18, 2002·Leukemia·L E van der KolkM H J van Oers
Oct 24, 2002·Blood·Bruce D Cheson
Feb 7, 2003·Proceedings of the National Academy of Sciences of the United States of America·Sean P BohenRonald Levy
Feb 15, 2003·Blood·Bradley C EkstrandSandra J Horning
May 2, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John D HainsworthUNKNOWN Minnie Pearl Cancer Research Network
Sep 17, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wen-Kai Weng, Ronald Levy
Mar 26, 2004·Seminars in Oncology·Wolfram Brugger
Jul 1, 2004·Blood·Guillaume CartronPhilippe Solal-Celigny
Sep 28, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Charles F EisenbeisPierluigi Porcu
Jan 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lucio N GordanJames W Lynch
Feb 8, 2005·Best Practice & Research. Clinical Haematology·Bernard Lemieux, Bertrand Coiffier
Mar 16, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·William WierdaMichael Keating
Mar 16, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael J KeatingHagop Kantarjian
May 4, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P FeugierB Coiffier
Jun 16, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Laurie H SehnJoseph M Connors
Sep 13, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bertrand Coiffier

❮ Previous
Next ❯

Citations

Apr 1, 2010·International Urology and Nephrology·Suhail Al-SalamSamra Abouchacra
Apr 25, 2007·Leukemia & Lymphoma·Deborah Rund
Feb 25, 2009·Expert Opinion on Biological Therapy·Magda MigkouEvangelos Terpos
Feb 27, 2009·Expert Opinion on Drug Safety·Matthew C Winter, B W Hancock
Nov 29, 2011·Best Practice & Research. Clinical Obstetrics & Gynaecology·Ihab El-Hemaidi, Susan E Robinson
Nov 21, 2007·American Journal of Clinical Pathology·Camille LaurentPierre Brousset
Oct 24, 2007·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Charles J DiskinWilliam J Cook
Sep 5, 2007·Molecular Immunology·Martin J GlennieRonald P Taylor
Oct 28, 2008·British Journal of Haematology·Christian Gisselbrecht
May 10, 2008·American Journal of Surgery·Melinda M MortensonJason B Fleming
Apr 2, 2010·Journal of Korean Medical Science·Won Jae YoonYong-Tae Kim
Mar 22, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Barbara-ann GuinnAlbert B Deisseroth
Aug 30, 2013·Experimental Biology and Medicine·Steve A Maxwell, Seyed Mousavi-Fard
Feb 18, 2016·Scientific Reports·Xing ChenQionghai Dai
Dec 16, 2017·Annals of Neurology·Ariele L Greenfield, Stephen L Hauser
Dec 26, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Federico PerosaFranco Dammacco
Dec 29, 2020·Transplant Immunology·Sam Arul DossDolly Daniel
Apr 21, 2021·Leukemia Research·Hongyan LiSheng-Yu Jin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Related Papers

The Urologic Clinics of North America
Grace Hyun, Franklin C Lowe
Hematology
Jane N WinterKoen Van Besien
Expert Opinion on Pharmacotherapy
Vikas Aurora, Jane N Winter
© 2022 Meta ULC. All rights reserved